The Vasculitis Foundation (VF) website is a resource that provides helpful information for people who are living with GPA or MPA and their caregivers.Visit the websiteor contact them at 1-800-277-9474. Get answers to the most frequently asked questions about treatment with Rituxan ...
Induction treatment: In the RAVE Trial, 64% of patients induced with Rituxan and GCC achieved complete remission* at 6 months compared with 53% of patients treated with CYC followed by AZA, thereby demonstrating non-inferiority.2 *Complete remission was defined as Birmingham Vasculitis Activity ...
Therefore, Rituxan is an effective therapeutic for blood cancers like B cell lymphoma or leukemia and certain autoimmune conditions, such as rheumatoid arthritis and some types of vasculitis, that have not responded to other treatments. Mechanism of Action ...
1. Indications and Usage for Rituxan 1.1 Non–Hodgkin's Lymphoma (NHL) RITUXAN is indicated for the treatment of adult patients with: Relapsed or refractory, low-grade or follicular, CD20-positive, B-cell NHL as a single agent. Previously untreated follicular, CD20-positive, B-cell NHL in...
Use an effective form of birth control to keep from getting pregnant during treatment with this medicine and for at least 12 months after the last dose. If you think you have become pregnant while receiving this medicine, tell your doctor right away. ...
RITUXAN is indicated for the treatment of adult patients with: Relapsed or refractory, low-grade or follicular, CD20-positive, B-cell NHL as a single agent. Previously untreated follicular, CD20-positive, B-cell NHL in combination with first line chemotherapy and, in patients achieving a complete...
RITUXAN HYCELA is indicated for the treatment of adult patients with: Relapsed or refractory, follicular lymphoma as a single agent. Previously untreated follicular lymphoma in combination with first line chemotherapy and, in patients achieving a complete or partial response to rituximab in combination ...